MedTrace Logo

Probiotics in Prevention of Common Cold

NCT02013934 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 899

Last updated 2018-04-17

No results posted yet for this study

Summary

The objective of this study is to assess the benefit and tolerability of a probiotic product in subjects with increased susceptibility to common cold.

Conditions

  • Viral Infections of the Upper Respiratory Tract

Interventions

DIETARY_SUPPLEMENT

Probiotic

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Probi AB

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-05-31
Completion
2016-05-17

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02013934 on ClinicalTrials.gov